SY
Delota Corp.
SYDRF · OTC
$0.10 +0.00% (+$0.00)
Market Cap $4.14M
P/E Ratio -
Div. Yield -
ROE 154.93%
Bulios Fair Price
$0.12
20.0% upside
Current Price
$0.1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SYDRF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
71 /100
Cheap EV/EBITDA 12.40x
P/S 0.13x
P/B 9.44x
Growth
34 /100
Stable Rev. growth 10.40%
FCF growth 16.10%
Book val. growth 35.40%
Profitability
10 /100
Weak Gross margin 14.39%
Net margin 3.33%
Op. margin 3.33%
Quality
15 /100
Poor ROIC 16.68%
ROE 154.93%
ROA 9.09%
Debt
3 /100
High Debt/Equity 10.89x
Current ratio 0.75x
Int. coverage -1.39x
Stability
28 /100
Unstable Beta -0.24x
Rev. volatility 22.86%
EPS volatility 184.70%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SYDRF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Robert Cameron-Takehiko Wickham
Employees
140
Headquarters
Concord